ResearcherUniversity of HelsinkiActive in the last 2 years
Olli Carpén
Matched on ORCID iD 0000-0002-7847-5706; OpenAlex author ID A5030148031. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 4
- Venous thromboembolism incidence and association with overall survival in pancreatic cancer: A Finnish nationwide cohort study. Co-author DOI 10.1002/cam4.70014↗
- Long-term nationwide trends in the treatment of and outcomes among pancreatic cancer patients. First author DOI 10.1016/j.ejso.2021.11.116↗
- CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study. Last author DOI 10.1080/0284186x.2019.1679881↗
- Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/1010428318761494↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hanna E. Seppänen · 4 shared papers, 2018–2024 · strength 0.63
- Paper Venous thromboembolism incidence and association with overall survival in pancreatic cancer: A Finnish nationwide cohor… DOI 10.1002/cam4.70014↗
- Paper Long-term nationwide trends in the treatment of and outcomes among pancreatic cancer patients. DOI 10.1016/j.ejso.2021.11.116↗
- Paper CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study. DOI 10.1080/0284186x.2019.1679881↗
- Caj H. Haglund · 3 shared papers, 2018–2024 · strength 0.49
- Paper Venous thromboembolism incidence and association with overall survival in pancreatic cancer: A Finnish nationwide cohor… DOI 10.1002/cam4.70014↗
- Paper Long-term nationwide trends in the treatment of and outcomes among pancreatic cancer patients. DOI 10.1016/j.ejso.2021.11.116↗
- Paper Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428318761494↗
- Panu Aaltonen · 2 shared papers, 2022–2024 · strength 0.40
- Pauli Antero Puolakkainen · 2 shared papers, 2022–2024 · strength 0.40
- Riitta Lassila · 2 shared papers, 2020–2024 · strength 0.37
- Paper Venous thromboembolism incidence and association with overall survival in pancreatic cancer: A Finnish nationwide cohor… DOI 10.1002/cam4.70014↗
- Paper CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study. DOI 10.1080/0284186x.2019.1679881↗
- Maija H. Peippo · 1 shared paper, 2020 · strength 0.15
- Kapo Saukkonen · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.